(Commission File Number) | (IRS Employer Identification No.) |
(Address of Principal Executive Offices) | (Zip Code) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Exhibit No. | Description | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
ENVISTA HOLDINGS CORPORATION | ||||||||
Date: November 1, 2023 | By: | /s/ Stephen Keller | ||||||
Stephen Keller | ||||||||
Principal Financial Officer |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Sales | $ | 631.3 | $ | 631.1 | $ | 1,920.9 | $ | 1,908.3 | |||||||||||||||
Cost of sales | 268.0 | 266.4 | 816.3 | 799.7 | |||||||||||||||||||
Gross profit | 363.3 | 364.7 | 1,104.6 | 1,108.6 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Selling, general and administrative | 257.7 | 264.2 | 796.7 | 801.9 | |||||||||||||||||||
Research and development | 22.3 | 26.0 | 73.6 | 75.5 | |||||||||||||||||||
Operating profit | 83.3 | 74.5 | 234.3 | 231.2 | |||||||||||||||||||
Nonoperating (expense) income: | |||||||||||||||||||||||
Other (expense) income | (32.1) | 0.3 | (24.7) | 0.9 | |||||||||||||||||||
Interest expense, net | (15.4) | (11.6) | (49.5) | (23.9) | |||||||||||||||||||
Income before income taxes | 35.8 | 63.2 | 160.1 | 208.2 | |||||||||||||||||||
Income tax expense | 14.3 | 13.6 | 42.9 | 43.7 | |||||||||||||||||||
Income from continuing operations, net of tax | 21.5 | 49.6 | 117.2 | 164.5 | |||||||||||||||||||
(Loss) Income from discontinued operations, net of tax | — | (2.0) | — | 5.1 | |||||||||||||||||||
Net income | $ | 21.5 | $ | 47.6 | $ | 117.2 | $ | 169.6 | |||||||||||||||
Earnings per share: | |||||||||||||||||||||||
Earnings from continuing operations - basic | $ | 0.13 | $ | 0.30 | $ | 0.71 | $ | 1.01 | |||||||||||||||
Earnings from continuing operations - diluted | $ | 0.12 | $ | 0.28 | $ | 0.66 | $ | 0.92 | |||||||||||||||
(Loss) Earnings from discontinued operations - basic | $ | — | $ | (0.01) | $ | — | $ | 0.03 | |||||||||||||||
(Loss) Earnings from discontinued operations - diluted | $ | — | $ | (0.01) | $ | — | $ | 0.03 | |||||||||||||||
Earnings - basic | $ | 0.13 | $ | 0.29 | $ | 0.71 | $ | 1.04 | |||||||||||||||
Earnings - diluted | $ | 0.12 | $ | 0.27 | $ | 0.66 | $ | 0.95 | |||||||||||||||
Average common stock and common equivalent shares outstanding: | |||||||||||||||||||||||
Basic | 168.2 | 163.1 | 165.3 | 162.7 | |||||||||||||||||||
Diluted | 175.2 | 176.9 | 176.3 | 178.4 | |||||||||||||||||||
As of | |||||||||||
September 29, 2023 | December 31, 2022 | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 824.2 | $ | 606.9 | |||||||
Trade accounts receivable, less allowance for credit losses of $16.0 and $16.2, respectively | 417.1 | 393.5 | |||||||||
Inventories, net | 278.8 | 300.8 | |||||||||
Prepaid expenses and other current assets | 120.6 | 123.4 | |||||||||
Total current assets | 1,640.7 | 1,424.6 | |||||||||
Property, plant and equipment, net | 304.0 | 293.6 | |||||||||
Operating lease right-of-use assets | 126.6 | 131.8 | |||||||||
Other long-term assets | 152.9 | 153.7 | |||||||||
Goodwill | 3,458.2 | 3,496.6 | |||||||||
Other intangible assets, net | 1,001.4 | 1,086.7 | |||||||||
Total assets | $ | 6,683.8 | $ | 6,587.0 | |||||||
LIABILITIES AND EQUITY | |||||||||||
Current liabilities: | |||||||||||
Short-term debt | $ | 115.1 | $ | 510.0 | |||||||
Trade accounts payable | 168.6 | 228.3 | |||||||||
Accrued expenses and other liabilities | 433.7 | 471.4 | |||||||||
Operating lease liabilities | 29.4 | 27.0 | |||||||||
Total current liabilities | 746.8 | 1,236.7 | |||||||||
Operating lease liabilities | 112.3 | 121.4 | |||||||||
Other long-term liabilities | 150.5 | 151.3 | |||||||||
Long-term debt | 1,381.0 | 870.7 | |||||||||
Commitments and contingencies | |||||||||||
Stockholders’ equity: | |||||||||||
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at September 29, 2023 and December 31, 2022 | — | — | |||||||||
Common stock - $0.01 par value, 500.0 million shares authorized; 173.2 million shares issued and 171.3 million shares outstanding at September 29, 2023; 163.7 million shares issued and 163.2 million shares outstanding at December 31, 2022 | 1.7 | 1.6 | |||||||||
Additional paid-in capital | 3,749.7 | 3,699.0 | |||||||||
Retained earnings | 848.6 | 731.4 | |||||||||
Accumulated other comprehensive loss | (306.8) | (225.1) | |||||||||
Total stockholders’ equity | 4,293.2 | 4,206.9 | |||||||||
Total liabilities and stockholders’ equity | $ | 6,683.8 | $ | 6,587.0 |
Nine Months Ended | |||||||||||
September 29, 2023 | September 30, 2022 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | 117.2 | $ | 169.6 | |||||||
Noncash items: | |||||||||||
Depreciation | 26.8 | 23.9 | |||||||||
Amortization | 75.9 | 78.2 | |||||||||
Allowance for credit losses | 3.5 | 3.8 | |||||||||
Stock-based compensation expense | 26.2 | 23.1 | |||||||||
Gain on equity investments, net | (3.6) | — | |||||||||
Gain on sale of property, plant and equipment | (2.0) | (1.1) | |||||||||
Gain on sale of KaVo treatment unit and instrument business | — | (8.9) | |||||||||
Restructuring charges | 0.7 | 5.5 | |||||||||
Impairment charges | 0.3 | 5.8 | |||||||||
Fair value adjustment of acquisition-related inventory | — | 7.7 | |||||||||
Amortization of right-of-use assets | 19.9 | 17.7 | |||||||||
Inducement expense related to exchange of convertible notes | 28.5 | — | |||||||||
Amortization of debt discount and issuance costs | 3.4 | 3.0 | |||||||||
Change in trade accounts receivable | (33.0) | (76.5) | |||||||||
Change in inventories | 9.4 | (35.9) | |||||||||
Change in trade accounts payable | (53.2) | 11.3 | |||||||||
Change in prepaid expenses and other assets | 5.4 | (21.7) | |||||||||
Change in accrued expenses and other liabilities | (26.1) | (109.7) | |||||||||
Change in operating lease liabilities | (25.6) | (23.4) | |||||||||
Net cash provided by operating activities | 173.7 | 72.4 | |||||||||
Cash flows from investing activities: | |||||||||||
Payments for additions to property, plant and equipment | (50.0) | (58.8) | |||||||||
Proceeds from sales of property, plant and equipment | — | 1.6 | |||||||||
Proceeds from sale of equity investment | 10.7 | — | |||||||||
Acquisitions, net of cash acquired | — | (696.2) | |||||||||
Proceeds from sale of KaVo treatment unit and instrument business, net | — | 59.8 | |||||||||
Proceeds from the settlement of derivative financial instruments | 1.1 | 55.9 | |||||||||
All other investing activities, net | (11.6) | (18.5) | |||||||||
Net cash used in investing activities | (49.8) | (656.2) | |||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from issuance of convertible notes due 2028 | 500.2 | — | |||||||||
Debt issuance costs related to issuance of convertible notes due 2028 | (13.5) | — | |||||||||
Principal paid related to exchange of convertible notes due 2025 | (401.2) | — | |||||||||
Proceeds from borrowings | 323.5 | 0.3 |
Repayment of borrowings | (288.8) | (0.5) | |||||||||
Debt issuance costs related to other borrowings | (4.5) | — | |||||||||
Proceeds from revolving line of credit | — | 124.0 | |||||||||
Repayment of revolving line of credit | — | (54.0) | |||||||||
Proceeds from stock option exercises | 7.5 | 19.9 | |||||||||
Tax withholding payment related to net settlement of equity awards | (7.8) | (8.9) | |||||||||
All other financing activities | 0.2 | — | |||||||||
Net cash provided by financing activities | 115.6 | 80.8 | |||||||||
Effect of exchange rate changes on cash and cash equivalents | (22.2) | (2.1) | |||||||||
Net change in cash and cash equivalents | 217.3 | (505.1) | |||||||||
Beginning balance of cash and cash equivalents | 606.9 | 1,073.6 | |||||||||
Ending balance of cash and cash equivalents | $ | 824.2 | $ | 568.5 |
GAAP | |||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Gross Profit | $ | 363.3 | $ | 364.7 | $ | 1,104.6 | $ | 1,108.6 | |||||||||||||||
Operating Profit From Continuing Operations | $ | 83.3 | $ | 74.5 | $ | 234.3 | $ | 231.2 | |||||||||||||||
Net Income From Continuing Operations | $ | 21.5 | $ | 49.6 | $ | 117.2 | $ | 164.5 | |||||||||||||||
Diluted EPS From Continuing Operations | $ | 0.12 | $ | 0.28 | $ | 0.66 | $ | 0.92 | |||||||||||||||
Operating Cash Flow | $ | 95.5 | $ | 46.7 | $ | 173.7 | $ | 72.4 |
NON-GAAP * | |||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Adjusted Gross Profit | $ | 364.3 | $ | 373.5 | $ | 1,111.9 | $ | 1,126.3 | |||||||||||||||
Adjusted Operating Profit | $ | 114.4 | $ | 119.5 | $ | 336.2 | $ | 354.3 | |||||||||||||||
Adjusted Net Income | $ | 75.5 | $ | 82.5 | $ | 219.5 | $ | 253.4 | |||||||||||||||
Adjusted Diluted EPS | $ | 0.43 | $ | 0.47 | $ | 1.25 | $ | 1.42 | |||||||||||||||
Adjusted EBITDA | $ | 123.5 | $ | 127.6 | $ | 363.7 | $ | 379.1 | |||||||||||||||
Free Cash Flow | $ | 77.1 | $ | 19.7 | $ | 123.7 | $ | 15.2 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Sales | |||||||||||||||||||||||
Specialty Products & Technologies | $ | 399.5 | $ | 395.4 | $ | 1,226.5 | $ | 1,200.2 | |||||||||||||||
Equipment & Consumables | 231.8 | 235.7 | 694.4 | 708.1 | |||||||||||||||||||
Total | $ | 631.3 | $ | 631.1 | $ | 1,920.9 | $ | 1,908.3 | |||||||||||||||
Operating Profit (Loss) | |||||||||||||||||||||||
Specialty Products & Technologies | $ | 61.4 | $ | 62.3 | $ | 188.2 | $ | 206.6 | |||||||||||||||
Equipment & Consumables | 43.9 | 44.7 | 124.8 | 120.4 | |||||||||||||||||||
Other | (22.0) | (32.5) | (78.7) | (95.8) | |||||||||||||||||||
Total | $ | 83.3 | $ | 74.5 | $ | 234.3 | $ | 231.2 | |||||||||||||||
Operating Margins | |||||||||||||||||||||||
Specialty Products & Technologies | 15.4 | % | 15.8 | % | 15.3 | % | 17.2 | % | |||||||||||||||
Equipment & Consumables | 18.9 | % | 19.0 | % | 18.0 | % | 17.0 | % | |||||||||||||||
Total | 13.2 | % | 11.8 | % | 12.2 | % | 12.1 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Gross Profit | $ | 363.3 | $ | 364.7 | $ | 1,104.6 | $ | 1,108.6 | |||||||||||||||
Restructuring costs and asset impairments A | 1.0 | 3.4 | 7.3 | 10.0 | |||||||||||||||||||
Fair value adjustment of acquisition-related inventory C | — | 5.4 | — | 7.7 | |||||||||||||||||||
Adjusted Gross Profit | $ | 364.3 | $ | 373.5 | $ | 1,111.9 | $ | 1,126.3 | |||||||||||||||
Gross Margin (Gross Profit / Sales) | 57.5 | % | 57.8 | % | 57.5 | % | 58.1 | % | |||||||||||||||
Adjusted Gross Margin (Adjusted Gross Profit / Sales) | 57.7 | % | 59.2 | % | 57.9 | % | 59.0 | % | |||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Consolidated | |||||||||||||||||||||||
Operating Profit | $ | 83.3 | $ | 74.5 | $ | 234.3 | $ | 231.2 | |||||||||||||||
Amortization of acquisition-related and other intangible assets | 23.9 | 27.9 | 75.9 | 78.2 | |||||||||||||||||||
Restructuring costs and asset impairments A | 6.8 | 9.6 | 24.7 | 28.1 | |||||||||||||||||||
Acquisition related expenses B | 0.4 | 2.1 | 1.3 | 14.6 | |||||||||||||||||||
Fair value adjustment of acquisition-related inventory C | — | 5.4 | — | 7.7 | |||||||||||||||||||
Contingent loss reserves F | — | — | — | 1.0 | |||||||||||||||||||
International tax credit G | — | — | — | (6.5) | |||||||||||||||||||
Adjusted Operating Profit | $ | 114.4 | $ | 119.5 | $ | 336.2 | $ | 354.3 | |||||||||||||||
Adjusted Operating Profit as a % of Sales | 18.1 | % | 18.9 | % | 17.5 | % | 18.6 | % | |||||||||||||||
Specialty Products & Technologies | |||||||||||||||||||||||
Operating Profit | $ | 61.4 | $ | 62.3 | $ | 188.2 | $ | 206.6 | |||||||||||||||
Amortization of acquisition-related and other intangible assets | 15.7 | 15.4 | 47.3 | 44.7 | |||||||||||||||||||
Restructuring costs and asset impairments A | 1.7 | 4.5 | 9.5 | 12.7 | |||||||||||||||||||
Contingent loss reserves F | — | — | — | 1.0 | |||||||||||||||||||
International tax credit G | — | — | — | (1.7) | |||||||||||||||||||
Adjusted Operating Profit | $ | 78.8 | $ | 82.2 | $ | 245.0 | $ | 263.3 | |||||||||||||||
Adjusted Operating Profit as a % of Sales | 19.7 | % | 20.8 | % | 20.0 | % | 21.9 | % | |||||||||||||||
Equipment & Consumables | |||||||||||||||||||||||
Operating Profit | $ | 43.9 | $ | 44.7 | $ | 124.8 | $ | 120.4 | |||||||||||||||
Amortization of acquisition-related and other intangible assets | 8.2 | 12.5 | 28.6 | 33.5 | |||||||||||||||||||
Restructuring costs and asset impairments A | 5.0 | 4.2 | 14.0 | 12.6 | |||||||||||||||||||
International tax credit G | — | — | — | (4.8) | |||||||||||||||||||
Adjusted Operating Profit | $ | 57.1 | $ | 61.4 | $ | 167.4 | $ | 161.7 | |||||||||||||||
Adjusted Operating Profit as a % of Sales | 24.6 | % | 26.1 | % | 24.1 | % | 22.8 | % | |||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Net Income From Continuing Operations | $ | 21.5 | $ | 49.6 | $ | 117.2 | $ | 164.5 | |||||||||||||||
Amortization of acquisition-related and other intangible assets | 23.9 | 27.9 | 75.9 | 78.2 | |||||||||||||||||||
Restructuring costs and asset impairments A | 6.8 | 9.6 | 24.7 | 28.1 | |||||||||||||||||||
Acquisition related expenses B | 0.4 | 2.1 | 1.3 | 14.6 | |||||||||||||||||||
Fair value adjustment of acquisition-related inventory C | — | 5.4 | — | 7.7 | |||||||||||||||||||
Loss (gain) on equity investments, net D | 3.3 | — | (3.6) | — | |||||||||||||||||||
Inducement and other expenses related to convertible notes exchange E | 29.0 | — | 29.0 | — | |||||||||||||||||||
Contingent loss reserves F | — | — | — | 1.0 | |||||||||||||||||||
International tax credit G | — | — | — | (6.5) | |||||||||||||||||||
Tax effect of adjustments reflected above H | (10.4) | (10.4) | (25.5) | (28.4) | |||||||||||||||||||
Discrete tax adjustments and other tax-related adjustments I | 1.0 | (1.7) | 0.5 | (5.8) | |||||||||||||||||||
Adjusted Net Income | $ | 75.5 | $ | 82.5 | $ | 219.5 | $ | 253.4 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Diluted Earnings From Continuing Operations Per Share | $ | 0.12 | $ | 0.28 | $ | 0.66 | $ | 0.92 | |||||||||||||||
Amortization of acquisition-related and other intangible assets | 0.14 | 0.16 | 0.43 | 0.44 | |||||||||||||||||||
Restructuring costs and asset impairments A | 0.04 | 0.05 | 0.14 | 0.16 | |||||||||||||||||||
Acquisition related expenses B | — | 0.01 | 0.01 | 0.08 | |||||||||||||||||||
Fair value adjustment of acquisition-related inventory C | — | 0.03 | — | 0.04 | |||||||||||||||||||
Loss (gain) on equity investments, net D | 0.02 | — | (0.02) | — | |||||||||||||||||||
Inducement and other expenses related to convertible notes exchange E | 0.17 | — | 0.16 | — | |||||||||||||||||||
Contingent loss reserves F | — | — | — | 0.01 | |||||||||||||||||||
International tax credit G | — | — | — | (0.04) | |||||||||||||||||||
Tax effect of adjustments reflected above H | (0.07) | (0.05) | (0.14) | (0.16) | |||||||||||||||||||
Discrete tax adjustments and other tax-related adjustments I | 0.01 | (0.01) | 0.01 | (0.03) | |||||||||||||||||||
Adjusted Diluted Earnings Per Share | $ | 0.43 | $ | 0.47 | $ | 1.25 | $ | 1.42 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Net Income From Continuing Operations | $ | 21.5 | $ | 49.6 | $ | 117.2 | $ | 164.5 | |||||||||||||||
Interest expense, net | 15.4 | 11.6 | 49.5 | 23.9 | |||||||||||||||||||
Income taxes | 14.3 | 13.6 | 42.9 | 43.7 | |||||||||||||||||||
Depreciation | 8.9 | 7.8 | 26.8 | 23.9 | |||||||||||||||||||
Amortization of acquisition-related and other intangible assets | 23.9 | 27.9 | 75.9 | 78.2 | |||||||||||||||||||
Restructuring costs and asset impairments A | 6.8 | 9.6 | 24.7 | 28.1 | |||||||||||||||||||
Acquisition related expenses B | 0.4 | 2.1 | 1.3 | 14.6 | |||||||||||||||||||
Fair value adjustment of acquisition-related inventory C | — | 5.4 | — | 7.7 | |||||||||||||||||||
Loss (gain) on equity investments, net D | 3.3 | — | (3.6) | — | |||||||||||||||||||
Inducement and other expenses related to convertible notes exchange E | 29.0 | — | 29.0 | — | |||||||||||||||||||
Contingent loss reserves F | — | — | — | 1.0 | |||||||||||||||||||
International tax credit G | — | — | — | (6.5) | |||||||||||||||||||
Adjusted EBITDA | $ | 123.5 | $ | 127.6 | $ | 363.7 | $ | 379.1 | |||||||||||||||
Adjusted EBITDA as a % of Sales | 19.6 | % | 20.2 | % | 18.9 | % | 19.9 | % | |||||||||||||||
Consolidated | % Change Three Month Period Ended September 29, 2023 vs. Comparable 2022 Period | % Change Nine Month Period Ended September 29, 2023 vs. Comparable 2022 Period | |||||||||
Total sales growth | — | % | 0.7 | % | |||||||
Plus the impact of: | |||||||||||
Acquisitions | — | % | (1.7) | % | |||||||
Currency exchange rates | 0.8 | % | 1.2 | % | |||||||
Core sales growth | 0.8 | % | 0.2 | % | |||||||
Specialty Products & Technologies | |||||||||||
Total sales growth | 1.0 | % | 2.2 | % | |||||||
Plus the impact of: | |||||||||||
Acquisitions | — | % | (1.4) | % | |||||||
Currency exchange rates | 1.2 | % | 1.5 | % | |||||||
Core sales growth | 2.2 | % | 2.3 | % | |||||||
Equipment & Consumables | |||||||||||
Total sales growth | (1.7) | % | (1.9) | % | |||||||
Plus the impact of: | |||||||||||
Acquisitions | — | % | (2.0) | % | |||||||
Currency exchange rates | 0.1 | % | 0.4 | % | |||||||
Core sales growth | (1.6) | % | (3.5) | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 29, 2023 | September 30, 2022 | September 29, 2023 | September 30, 2022 | ||||||||||||||||||||
Net Operating Cash Provided by Operating Activities | $ | 95.5 | $ | 46.7 | $ | 173.7 | $ | 72.4 | |||||||||||||||
Less: payments for additions to property, plant and equipment (capital expenditures) | (18.4) | (26.9) | (50.0) | (58.8) | |||||||||||||||||||
Plus: proceeds from sales of property, plant and equipment (capital disposals) | — | (0.1) | — | 1.6 | |||||||||||||||||||
Free Cash Flow | $ | 77.1 | $ | 19.7 | $ | 123.7 | $ | 15.2 | |||||||||||||||
Cover |
Nov. 01, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Nov. 01, 2023 |
Entity Registrant Name | ENVISTA HOLDINGS CORPORATION |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-39054 |
Entity Tax Identification Number | 83-2206728 |
Entity Address, Address Line One | 200 S. Kraemer Blvd., Building E |
Entity Address, City or Town | Brea, |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92821 |
City Area Code | 714 |
Local Phone Number | 817-7000 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, $0.01 par value |
Trading Symbol | NVST |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001757073 |
Amendment Flag | false |
XR/3.$5C(BN=H!RDTA;VW!61C&<
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MO;<&%1T;A[R O%F )ZX@5R?/*AT_1=J7Y!\7@ KQUC92G9) 75Y:GD
M&*:2G@0D(W&S+Z>7#7GIM\1=OE9O&XUN:^UET[#67GONM5;=:+6V>^WSUSIV
M_34&V[2ZKS#89GW]1ZLR6# !-GTMR$4\XL'?W]3?9/=E$A*$>#"PK'?^)J4V
M6O?(B+MH'9_8H^_,FB]3YHO^DGY0JF'7:K7S(]-"ZI]??[):YO3TZ2(9NIO,
M22T+AYG5TEHA9W4WP'RFSW#?(&:7F/ZW=H;+7#-Q?JLP45!B7..Q^IRT(/'8
M2#RF C.I8[5R+U_$I#TSJ=WM&FW=
MF*3?JJ^%)5' &.C'"$\<8B$5+]G*D/B1/;N11Z.?V-5;]9V;]IIYJ-5F;R.W
M5B7V%H:]5LTR&T:+&%QF!G<*QF#]#!PMC*8"AE]N1EG+"BRE%\0BEL<_-LF^
MV-J[H7?H_@[]9%$+^5[M%*EEQC;LIN:R?BM\7U;EN1>!K'6E6H$,O<"3=26\
M!_$2OZF :Z_=;&]K.Q?4>BHBD\#!L8E)>C.IW6V1).G.I(YI;9NH0+Z$%KY$
M86R-KR(6/'(&BT5=JK;#:].VE/8\:M$FO.X\:M=S1\B(1_OF4=-HZL8C_0P!
M+8R+ N[N3@.5K[C#6T2QZ^Q^=[>H+EFI^-INY%:GQ-<"\-6N-TA@R\E8:]LX
M):70:V,:%7 /]SH,PHEU=)3NX[[%&L;A4-!V+KU#/['40M0+OIU[(TML+\H[
MJ]@6[E'=-JRW^FQGT)[3/'_,;8U=8M'>1,AN&&T2(6WYL_7I J04IPSWS!8\$D68[#_O$8_O%R\Z2
MH+/LUK;K5$$-C2(RJ6Z5( RCMV:0418_#.Z/$Q$-*QIG:=JY=R3)3-@[D^J'
M/ )VHY.LGVZ.GM_]>GJ[NKREIU=7[#+__GS
MZNY_7W*>:88G=2"\&X[1OM[)T;9-+<#7&645[(GL;)OO\9[G>XDG7G# K0@%
M=*N6@W@["*-$QL9@G.71#FBH2YIF4>,M>D:L=(
M%DZIC?@3'E&KV,X%5@&G+ ;-F63;G4,6A*R:(7?F.-%8K#Q,,F.\5VPOHU$_
MZ.8Y[61LQ*3V0;>;JF9!+"9%OE0[%'B%ZNI7#)>LB,5SP]O&@FF/L_ AZDU.
MF>W(N"G5>:1VHY5[%S 7'0ID$)6*L5;-KF^=]*'9YE@!=T/(=)I&FFWJ]J ]
MD^S\CI5^$1B]-<+".9+JAEJLIGG( 12,+X?/O+ $:P?1LR)A.LE\F1$Y4KNU:G@GOXLTL[D)',F
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MDBGN*FD>L@L1&3*;*1G:N2JT,?,!5(PJL:W;,ER$!X;,9,WJ15MD7]M&YVLG62"Z+
M(V;\)53[W\7CT^RA M[.@--8'.H7FB*-(G#BH'$S?!53-KBIMJSD/$J,:4-=
MM8=!]UNS#A_1ND=.4KAKVH<9O9_YEDS) XQ,7\A8_EQ5I/85];*.SW:W]\;%
M>V:2W#6>/V!GS+, B^FU9?W S286$#,M0Q$FL1N3$MZB01RJR#BH997VXGG.
M,])O3&OL94DJ=D>>=AW1W7B8\;6>3SF<[IQ?_BVWR_F;#
;B^K^Q*IW4BLD17W@5#&$I'!
M8+(3%/H3A8=L@N-ZVI7@6;/C0%AP#W.ZF*],P^>Z+&+1%=79+YC@-(4O-YC,
M8(9K(F$)79#2:^*%!H*[F!)2!:RCQ204GMH
Y0397QE"$X:Z D&3&R'
M^W/]K=WF8\[#QI8I, $D\;XX=H(2[\"2R(T*G"?NW;1KP_=MCX-BP7W*F61=
M%AQ';7L)S=>^4),9%=$2"CWH1EGB6(K$4\^R",9A6C0G(D]6, Z4!3
[CMA&.0[[I\D,NM
MLNZ_S(PG-M2WSC!&['.YXN(+LN%EPYW*YVP8Z;D1LG@ ZAH58S^9Q$T#QP?;
M5#TA?8!9TB %Y?=2XV;ZS3'H:I
M=1V/08@6=SEF9HX?? K'&.K!(3)C;\VD!JIM!F-MW?G_7L+0-
MC.I7=JXH=U8AXOP!#\KGKXQ'+K&&>JC=SJV&* I#D'N1B=_-;6T1Y AR+XUD
M$.8(
[Y!AO96_ D*N^6M>])807'P$YR]-20@F!.LS
M:ZMFF8UMBST3A@G#&LP:,=S1$\/[/@